ICMR Working With Global Institutions To Explore Vaccine Candidates Against ‘WHO Blueprint Priority Pathogens’: Government

New Delhi: The ICMR has collaborated with two global institutions to explore available vaccine candidates against “WHO Blueprint Priority Pathogens”, the government told Lok Sabha on Friday (July 21). Minister of State for Health SP Singh Baghel was replying to a question on the steps being taken by the government to speed up the development of vaccines for “emerging/reemerging pathogens.”

The Indian Council of Medical Research (ICMR) has collaborated with the Coalition for Epidemic Preparedness Innovations and the International Vaccine Institute, Korea, for exploration of available vaccine candidates against “WHO Blueprint Priority Pathogens” and the feasibility of bringing available technology to India, he said. On the steps being taken by the government to promote development and production of vaccines for diseases such as polio, smallpox and measles, Mr Baghel said the ICMR has been designated as the secretariat for the National authority for Containment (NAC) of polio viruses.

Also Read: Childhood Vaccination Rates Begin To Recover Post-Pandemic: United Nations

The ICMR has approved three proposals for development of polio vaccines — nOPV2 fill and finish and Sabine S19 IPV manufacturing at Biological E in Hyderabad, establishment of polio essential facility for setting up Sabine IPV manufacturing facility at Reliance Life Science Pvt Ltd, and establishment of polio essential facility for setting up Sabine IPV manufacturing facility at Bharat Biotech International Ltd. It has been informed by the Department of Biotechnology (DBT) that along with its industry-academia interface agency, Biotechnology Industry Research Assistance Council, it has facilitated strengthening of the ecosystem for vaccine development through various schemes and programmes, the Union minister said in a written reply.

The schemes and programmes include the National Biopharma Mission, the Mission Ind-CEPI (Coalition for Epidemic Preparedness Innovations) and the Mission COVID Suraksha,Mr Baghel said. The DBT has also taken steps to streamline bio-safety regulation, whereby, a rapid response regulatory framework for COVID-19 vaccine development was issued, he said and added that an online portal — Indian Biosafety Knowledge Portal — has also been launched for submission, processing and approval of applications. The frequency of the meetings of the review committee on genetic manipulation has also been increased and are held every fortnight, the minister informed the House.

ICMR institutes — National Institute of Virology, Pune; National Institute for Research in Tuberculosis, Chennai; National Institute of Epidemiology, Chennai; National Animal Resource Facility for Biomedical Research, Hyderabad; National Institute of Cholera and Enteric Diseases, Kolkata; and the Delhi-based ICMR –are working on different aspects of vaccine research and development, Mr Baghel said.

The DBT has informed that its three autonomous institutes — National Institute of Immunology, Delhi; Translational Health Science and Technology Institute (THSTI), Faridabad; and Institute of Life Sciences (ILS), Bhubaneshwar — have established facilities for development of animal models and assays for vaccine research, he said.

Also Read: One Child Or Youth Died In Every 4.4 Seconds In 2021 Due To Lack Of Basic Health Care: UN Report

(This story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol have been working towards a clean and healthy India since 2014 via the Banega Swachh India initiative, which is helmed by Campaign Ambassador Amitabh Bachchan. The campaign aims to highlight the inter-dependency of humans and the environment, and of humans on one another with the focus on One Health, One Planet, One Future – Leaving No One Behind. It stresses on the need to take care of, and consider, everyone’s health in India – especially vulnerable communities – theLGBTQ population,indigenous people, India’s different tribes, ethnic and linguistic minorities, people with disabilities, migrants, geographically remote populations, gender and sexual minorities. In wake of the currentCOVID-19 pandemic, the need for WASH (Water,SanitationandHygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign will continue to raise awareness on the same along with focussing on the importance of nutrition and healthcare for women and children, fightmalnutrition, mental wellbeing, self care, science and health,adolescent health & gender awareness. Along with the health of people, the campaign has realised the need to also take care of the health of the eco-system. Our environment is fragile due to human activity, which is not only over-exploiting available resources, but also generating immense pollution as a result of using and extracting those resources. The imbalance has also led to immense biodiversity loss that has caused one of the biggest threats to human survival – climate change. It has now been described as a “code red for humanity.” The campaign will continue to cover issues likeair pollution,waste management,plastic ban,manual scavengingand sanitation workers andmenstrual hygiene. Banega Swasth India will also be taking forward the dream of Swasth Bharat, the campaign feels that only a Swachh or clean India wheretoiletsare used andopen defecation free (ODF)status achieved as part of the Swachh Bharat Abhiyan launched byPrime Minister Narendra Modiin 2014, can eradicate diseases like diahorrea and the country can become a Swasth or healthy India.